The U.S. Centers for Disease Control and Prevention (CDC) released a detailed account on Thursday of the agency’s response to the Ebola virus epidemic of 2014-2016.
The report, a special supplement to the CDC’s Morbidity and Mortality Weekly Report (MMWR), comes on the second anniversary of... Read More »
A team at the Edgewood Chemical Biological Center (ECBC) has developed a means for Department of Defense (DoD) labs across the globe to quickly obtain a genomic analysis of unknown and potentially hazardous biological samples without incurring the cost and risk of shipping them to a robust... Read More »
The Infectious Diseases Society of America (IDSA) announced its support on Thursday for a bill authored by U.S. Sen. Angus King (I-ME) that aims to control the spread of Zika virus.
The Strengthening Mosquito Abatement for Safety and Health (SMASH) Act aims strengthen the nation’s ability to... Read More »
The Edgewood Chemical Biological Center (ECBC) recently announced that is has developed a decontamination spray that enables soldiers at the unit level to decontaminate vehicle surfaces in the field immediately after exposure to a chemical warfare agent and continue with their mission.
The... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) provided BioCryst Pharmaceuticals with additional funding on Monday for efficacy studies of BCX4430 in non-human primates to further assist effective dose regimens.
BCX4430 is a broad-spectrum antiviral that is advancing toward... Read More »
An independent panel of public health, emergency response and communication experts issued a report on Friday on the Ebola epidemic of 2014, identifying recommendations to improve the U.S. Department of Health and Human Services (HHS) response to urgent public health threats.
Concerns... Read More »
The Partnership for Research on Ebola virus in Liberia (PREVAIL) on Monday opened PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material - RNA - in their semen.
The trial is sponsored by the National... Read More »
A coalition of research institutions published a report in the Clinical Infectious Disease Journal on Wednesday that analyzed the immune responses of Ebola patients treated in the United States.
The coalition includes the U.S. Centers for Disease and Control (CDC), the Emory University School... Read More »
The National Institutes of Allergy and Infectious Diseases (NIAID) released a report on Tuesday detailing how a single dose of either of two experimental Zika vaccines protected mice infected with the virus for four to eight weeks after receiving the inoculations.
NIAID said that this... Read More »
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) presented data on Monday regarding gene sequences and the global variations in malaria parasites.
NIAID researchers determined the genomes of approximately 200 P. vivax strains that recently infected people in... Read More »
The European Center for Disease Control and Prevention (ECDC) produced a policy briefing on Monday highlighting preparedness measures to minimize the risk of Zika virus spreading in continental Europe.
The briefing is primarily to protect pregnant women and those who wish to become pregnant,... Read More »
The World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization presented evidence on Friday that yellow fever vaccine given at one-fifth of the regular dose could be used to control an outbreak in case of vaccine shortages.
The reduced dose, known as fractional... Read More »
The National International Health Regulations (IHR) of the United States notified the Pan-American Health Organization (PAHO) and the World Health Organization (WHO) on Tuesday of the first confirmed case of locally-acquired Chikungunya virus in the state of Texas.
The patient became ill in... Read More »